Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study

European Journal of Medicinal Chemistry
2010.0

Abstract

Novel derivatives of quinazoline (1-27) have been synthesized and tested for their antitumor activity against three tumor cell lines among these cell lines the human breast carcinoma cell line (MCF-7) in which EGFR is highly expressed. All tested compounds showed potent and selective activity against breast cancer (MCF-7) with IC(50) range of 3.35-6.81 microg/ml. With regarding broad-spectrum activity compounds 5, 9, 15, 18 and 20 exploited potent antitumor against human liver cell line (HEPG2), human breast cell line (MCF-7) and human cervix cell line (HELA) with IC(50) range of 3.35-5.59 microg/ml. Virtual screening was carried out through docking the designed compounds into the ATP binding site of epidermal growth factor receptor (EGFR) to predict if these compounds have analogous binding mode to the EGFR inhibitors.

DOI： 10.1016/j.ejmech.2010.06.013

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study
European Journal of Medicinal Chemistry 2010.0
Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor
European Journal of Medicinal Chemistry 2016.0
Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors
European Journal of Medicinal Chemistry 2018.0
Synthesis and in vitro biological evaluation of novel quinazoline derivatives
Bioorganic & Medicinal Chemistry Letters 2017.0
Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity
European Journal of Medicinal Chemistry 2015.0
Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: Molecular docking study
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives
European Journal of Medicinal Chemistry 2009.0
Design, synthesis and biological evaluation of novel 2,4-disubstituted quinazoline derivatives targeting H1975 cells via EGFR-PI3K signaling pathway
Bioorganic & Medicinal Chemistry 2021.0
Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines
Bioorganic & Medicinal Chemistry Letters 2021.0
Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors
European Journal of Medicinal Chemistry 2013.0